Home > Insider Trading > Filing (0000929638-23-003344)

Filing Details

Accession Number:: 0000929638-23-003344
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-12-05 17:21:02
Reporting Period:: 2023-12-01

Accepted Time:: 2023-12-05 17:21:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1373670	Green Brick Partners Inc.	GRBK	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1079114	Greenlight Capital Inc	140 East 45Th Street 24Th Floor New York NY 10017	No	No	No	No
1240451	David Einhorn	140 East 45Th Street 24Th Floor New York NY 10017	No	No	No	No
1300763	Dme Advisors, Lp	140 East 45Th Street 24Th Floor New York NY 10017	No	No	No	No
1358081	Dme Advisors Gp, L.l.c.	140 East 45Th Street 24Th Floor New York NY 10017	No	No	No	No
1489933	Dme Capital Management, Lp	140 East 45Th Street 24Th Floor New York NY 10017	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-12-01	519,210	$44.65	8,248,438	No	4	S	Indirect	See footnote
Common Stock	Disposition	2023-12-04	418,290	$44.81	7,830,148	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	827,082	Direct
Common Stock	42,028	Indirect	By simplified employee pension plan
Common Stock	834,545	Indirect	See footnote
Common Stock	2,740,190	Indirect	See footnote

Footnotes

David Einhorn is the president of Greenlight Capital, Inc. ("Greenlight Inc.") and the senior manager of DME Advisors GP, LLC ("DME GP"). DME GP is the general partner of DME Advisors, LP ("DME") and DME Capital Management, LP ("DME CM" and, together with Greenlight Inc., DME GP, DME, and Mr. Einhorn, the "Reporting Persons"). Mr. Einhorn may be deemed to beneficially own the securities reported herein by virtue of his positions with respect to Greenlight Inc. and DME GP.
Pursuant to Rule 16a-1 under the Securities Exchange Act of 1934, as amended (the "Act"), the Reporting Persons disclaim beneficial ownership of the Common Stock (as defined below) except to the extent of their respective pecuniary interests therein. The filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is for the purposes of Section 16(a) of the Act, or otherwise, the beneficial owner of any of the Common Stock held for the account of GCOP, Ltd., GCOM, the SPVs, or SILP (each as defined below).
The Reporting Persons control the disposition and voting of shares of Common Stock ("Common Stock") of the Issuer held for the account of Greenlight Capital Offshore Partners, Ltd. ("GCOP, Ltd."), Greenlight Capital Offshore Master, Ltd. ("GCOM"), and special purpose vehicles created by GCOP, Ltd. and GCOM (the "SPVs"), Solasglas Investments, LP ("SILP"), in the respective capacities and quantities further described in the footnotes below.
DME CM controls the voting and disposition of 7,830,148 shares of Common Stock held for the accounts of GCOM and the SPVs, of which in each case DME CM acts as investment advisor.
Greenlight Inc. controls the voting and disposition of 834,545 shares of Common Stock held for the account of GCOP, Ltd. of which Greenlight Inc. acts as investment advisor.
DME controls the voting and disposition of 2,740,190 shares of Common Stock held for the account of SILP, of which DME serves as investment advisor.
Sales made pursuant to a previously disclosed agreement.